Molecular Biomarkers Affecting Moyamoya Disease.

Area of Science:

• Neuroscience
• Genetics
• Vascular Biology

Background:

• Moyamoya disease (MMD) pathogenesis is not fully understood.
• RNF 213 gene variations are strongly associated with MMD susceptibility.
• Circulating factors potentially contribute to MMD development.

Purpose of the Study:

• To summarize the hypothesized pathophysiology of circulating factors in MMD.
• To explore the interactive modulation between these factors in MMD.
• To highlight the potential of circulating biomarkers for early MMD detection.

Main Methods:

• Review of existing literature on MMD genetics and circulating factors.
• Analysis of hypothesized roles of growth factors, progenitor cells, and inflammatory mediators.
• Discussion of proteins involved in intimal hyperplasia and collateral formation.

Main Results:

• RNF 213 polymorphism is a key genetic risk factor for MMD.
• Multiple circulating factors, including angiogenic and inflammatory mediators, are implicated in MMD.
• These factors may influence intimal hyperplasia, collateralization, and smooth muscle cell behavior.

Conclusions:

• Circulating biomarkers hold promise for early MMD diagnosis.
• Understanding the interplay of genetic and circulating factors is crucial for MMD research.
• Further investigation into these pathways could reveal novel therapeutic targets for MMD.